Generation of HLA-DP transgenic pigs for the study of xenotransplantation

International Surgery

Volumn 84, Issue 2, 1999, Pages 176-182

  Tu, Ching Fu ^a   Tsuji, Kimiyoshi ^b   Lee, Kun Hsiung ^a   Chu, Redman ^c   Sun, Tzeli Julia ^c   Lee, Yuan Chi ^d   Weng, Chung Nan ^a   Lee, Chun Jean ^d  

^a Pig Research Institute Taiwan   (Taiwan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

HLA II; Microinjection; Transgenic pigs; Xenotransplantation

Indexed keywords

HLA DP ANTIGEN;

ANIMAL; ARTICLE; FEMALE; GENE EXPRESSION; GENE TRANSFER; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SWINE; TRANSGENIC ANIMAL; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BLOTTING, SOUTHERN; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; HLA-DP ANTIGENS; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033109930     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cooper DK. Is xenotransplantation a realistic clinical option? Transplant Proc 1992; 24: 2393-6
2. Cozzi E, Langford GA, Richards A, Elsome K, Lancaster R, Chen Petal. Expression of human decay accelerating factor in transgenic pigs. Transplant Proc 1994; 26: 1402-3.
3. McCurry KR, Kooyman DL, Alvarado CG, Cotterell AH, Martin MJ, Logan M et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995; 1: 423-7
4. Fodor WL, Williams BL, Matis LA, Madri JA, Rollins SA, Knight JW et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994; 91: 11153-7
5. Schmoeckel M, Nollert G, Shahmohammadi M, Young VK, Chavez G, Kasper-Konig W et al. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts. Transplantation 1996; 62: 729-34.
6. Byrne GW, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 1997; 63: 149-55.
7. Kroshus TJ, Bolman III RM, Dalmasso AP, Rollins SA, Guilmette ER, Williams BL et al. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 1996; 61: 1513-21
8. Storck M, Abendroth D, Prestel R, Pino-Chavez G, Muller-Hoker J, White DJG et al Morphology of hDAF (CD55) transgenic pig kidneys following ex-vivo hemoperfusion with human blood. Transplantation 1997; 63: 304-10
9. Pierson 3rd RN, Pino-Chavez G, Young VK, Kasper-Konig W, White DJG, Wallwork J. Expression of human decay accelerating factor may protect pig lung from hyperacute rejection by human blood. J Heart Lung Transplant 1997; 16: 231-9.
10. Diamond LE, McCurry KR, Martin MJ, McClellan SB, Oldham ER, Platt JL et al. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 1996; 61: 1241-9
11. Tsuji K, Inoko H, Hagihara M, Shimura T, Sato T, Ando A. Role of HLADP antigen in xenogeneic isoskin grafts using transgenic mice. Transplant Proc 1993; 25: 136-7
12. Hagihara M, Shimura T, Tsuchida F, Takebe K, Munkhbat B, Tsuji K. MLR and skin graft studies in xenogeneic iso-, allo-, and xeno-combinations using HLA-DP and DQ transgenic mice. Transplant Proc 1994; 26: 967-8
13. Hagihara M, Shimura T, Tsuchida F, Takebe K, Munkbat B, Tsuji K. Mixed lymphocyte reaction and skin graft using HLA-DP and DQ transgenic mice. Transplant Proc 1994; 26: 1868
14. Hagihara M, Shimura T, Takebe K, Munkhbat B, Sato T, Tsuchida F et al. Xenogeneic iso-skin graft and mixed lymphocyte reaction studies using HLA-DP transgenic mice. Transpl Immunol 1996; 4: 220-6
15. Tsuji K, Hagihara M, Sato T, Shimura T, Takebe K, Munkbat B. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation. Transplant Proc 1994; 26: 2441-3
16. Rogers NJ, Dorling A, Moore M. Xenotransplantation: steps towards a clinical reality. Immunol Today 1998; 19: 206-8
17. Sharma A, Okabe J, Birch P, McClellan SB, Martin MJ, Platt JL et al. Reduction in the level of Gal-(alpha-1,3)-Gal in transgenic mice and pigs by the expression of an alpha-(1,2)-fucosyltransferase. Proc Natl Acad Sci USA 1996; 93: 7190-5
18. Morigi M, Zoja C, Colleoni S, Angioletti S, Imberti B, Remuzzi A et al. Xenogeneic human serum promotes leukocyte adhesion to porcine endothelium under flow conditions, possibly through the activation of the transcription factor NF-KB. Xenotransplantation 1998; 5: 57-60
19. Mark W, Hechenleitner P, Candinas D, Miyatake T, Koyamada N, Margreiter R et al. Xenograft accommodation is accompanied by intragraft Th2 cytokines and vascular expression of protective genes. Xenotransplantation 1997; 4: 154-60
20. Haeney M. The immunological background to transplantation. J Antimicrob Chemother 1995; 36 (Suppl B): 1-9
21. Kawagishi N, Moller E, Satake M. Human CD8 responder cells can be directly activated to proliferate and to produce IL-2 following stimulation by allogeneic, but not by xenogeneic, porcine blood mononuclear cells. Xenotransplantation 1997; 4: 95-102
22. Kirk AD, Li RA, Kinch MS, Abernethy KA, Doyle C, Bollinger RR. The human antiporcine cellular repertoire. In vitro studies of acquired and innate cellular responsiveness. Transplantation 1993; 55: 924-31
23. Watier H, Vallee I, Thibault G, Lalmanach AC, Lacord M, Gruel Y et al. Effect of human inflammatory cytokines on porcine endothelial cell MHC molecule expression: unique role for TNF-alpha in MHC class-II induction. Transplant Proc 1994, 26: 1152-5
24. Tu CF, Sato T, Hagihara M, Lee KH, Lee YC, Weng CN et al. The expression of HLA-DP antigen on peripheral blood mononuclear cells of HLA-DP transgenic pigs. Tranplant Proc 1998; In press